 |
인쇄하기
취소
|
Korean biotech firm signs $290 million deal with Roche
Digital Biotech Co., a local biotech company, said on January 19 that it has signed a $290 million deal with Roche Holding AG to transfer its candidate dementia treatment to the Switzerland based pharmaceutical giant.
A Korean biotech company said that under the agreement, it will transfer its "DBT-066 RAGE" suppressor technology to Roche and participate in joint research to successfully com...
A Korean biotech company said that under the agreement, it will transfer its "DBT-066 RAGE" suppressor technology to Roche and participate in joint research to successfully com...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.